Latest News & Updates on Veeva CRM

Veeva Systems has enhanced its Veeva DQS, a clinical data platform, to automate data aggregation, cleaning, and management for clinical trials. The platform centralizes data from various sources, aut...omates discrepancy detection, and streamlines query management, enabling faster data readiness and improved collaboration among data managers.
Show More..

Veeva Systems has launched new products focused on environmental, health, and safety, as well as AI-driven content review. The resolution of a dispute with IQVIA now allows Veeva to integrate industr...y-leading datasets into its Commercial Cloud, expanding its market and improving product adoption.
Show More..

Veeva Systems has launched Veeva EHS, a new cloud application that integrates with its Quality Cloud platform to enhance environmental, health, and safety management. This expansion aims to automate ...safety processes and improve transparency for regulated manufacturers and testing sites, potentially broadening Veeva's reach beyond the life sciences sector.
Show More..

Veeva Systems launched Veeva EHS, a new application within its Quality Cloud, aimed at enhancing environmental, health, and safety management. The solution integrates with Veeva QMS and Veeva Trainin...g, providing real-time risk visibility and compliance automation. This expansion strengthens Veeva's competitive position in the EHS software market.
Show More..

Veeva Systems has launched Veeva EHS, a new application within Veeva Quality Cloud, designed for proactive risk management and intelligent automation in environmental, health, and safety processes. T...he application integrates with Veeva QMS and Veeva Training to streamline workflows, enhance data integrity, and ensure compliance. It will be available for early adopters in August 2026.
Show More..

Veeva Systems has introduced the Veeva EHS application within the Veeva Quality Cloud, enhancing its offerings in environmental health and safety management. This integration aims to streamline compl...iance and quality management processes for life sciences companies.
Show More..

Veeva Systems introduces enhancements in Veeva RTSM, focusing on resupply buffers to manage inventory parameters effectively. The update allows clinical supply teams to use static buffers or predicti...ve offsets, optimizing flexibility and reducing waste during trials.
Show More..

Veeva Systems has enhanced the resupply logic in its Veeva RTSM platform. The update improves inventory management by evaluating event dates and expiration parameters to optimize stock usage and prev...ent premature kit replacements. The system now also logs all resupply runs, offering a comprehensive audit trail.
Show More..

Veeva Systems has launched Veeva Vault CDMS, a next-generation cloud application designed to streamline clinical data management. This single application integrates coding, EDC, data cleaning, and re...porting, allowing life sciences companies to manage all trial data efficiently. Vault CDMS aims to replace multiple tools, providing a complete view of clinical data for faster insights and execution. It is part of the Veeva Vault Clinical Suite, enhancing trial processes on a unified cloud platform.
Show More..

Veeva Systems has introduced Veeva Vault CTMS, the first cloud-based application unifying CTMS and eTMF for clinical operations. This solution offers life sciences companies a single source for clini...cal data, real-time visibility, and seamless stakeholder collaboration. Vault CTMS, part of the Veeva Vault Clinical Suite, aims to streamline clinical trial processes and is expected to be available in Q1 2017.
Show More..

Veeva Systems has launched Veeva ePRO, a new application designed to enhance patient-reported outcomes in digital clinical trials. This tool allows patients to complete assessments via mobile or web,... providing real-time data access for sponsors and research sites. Part of the Veeva Vault Clinical Suite, ePRO aims to streamline trial activities and improve patient retention by addressing common challenges in clinical trials.
Show More..

Veeva Systems announced the launch of Veeva Falcon, an agentic platform designed to enhance drug development processes. Falcon integrates with Veeva Development Cloud applications to improve speed, r...educe costs, and ensure compliance in clinical, regulatory, and safety operations. The platform is part of Veeva's AI solutions for life sciences and will be available to early adopters in November 2026.
Show More..

Veeva Systems has launched Falcon, a new agentic platform designed to enhance drug development processes. This platform aims to streamline operations and improve efficiency in the life sciences indus...try.
Show More..

Veeva Systems has introduced the Agentic platform, designed to enhance drug development projects. This new platform aims to streamline processes and improve efficiency in the life sciences industry.

Veeva Systems has introduced Falcon, an agentic platform designed to enhance life sciences operations. The platform includes standard agents to streamline processes and improve efficiency. This launc...h underscores Veeva's commitment to providing innovative solutions tailored to the life sciences industry.
Show More..

Veeva Systems has introduced the Falcon platform to enhance drug development efficiency for biopharma companies. The platform integrates with Veeva Development Cloud applications to reduce costs and ...speed up processes, focusing on trial master file document intake, quality control, regulatory correspondence, and safety case triage. Falcon is part of Veeva AI and will be available to early adopters in November 2026, reinforcing Veeva's leadership in life sciences.
Show More..

Veeva Systems has launched the Falcon Agentic Platform, an AI-driven solution integrated with its Development Cloud to streamline clinical, regulatory, and safety workflows. The platform aims to redu...ce costs and accelerate drug development, with early access available in November 2026. Additionally, Teva Pharmaceuticals will globally deploy Veeva Vault CRM, enhancing commercial operations with AI-driven insights.
Show More..

Veeva Systems has launched Falcon, an AI-driven platform to automate drug development processes, focusing on trial master file document intake, health authority correspondence, and safety case triage.... Available for early adopters in November 2026, Falcon aims to reduce costs, increase speed, and ensure compliance for biopharmaceutical companies, positioning Veeva as a leader in AI solutions for life sciences.
Show More..

Veeva Systems announced Veeva Falcon, an agentic platform integrated with Veeva Development Cloud applications to enhance drug development processes. Falcon focuses on trial master file management, r...egulatory correspondence, and safety case triage, aiming to reduce costs and increase speed for biopharmas. Early adopter availability is planned for November 2026.
Show More..

Veeva Systems announced Falcon, an agentic platform integrated with Veeva Development Cloud applications to enhance drug development processes. Falcon aims to reduce costs and increase speed in clini...cal, regulatory, and safety operations for biopharma companies. It is part of Veeva's AI solutions and will be available for early adopters in November 2026.
Show More..

Veeva Systems is gaining momentum in the randomization and trial supply management (RTSM) market, becoming a key growth driver for its R&D business. A major pharma win highlights customer confidence ...in Veeva's clinical ecosystem. The RTSM platform, alongside EDC and eCOA, presents a multibillion-dollar opportunity, with a focus on expanding CRO partnerships to enhance its Development Cloud platform.
Show More..

Veeva Systems showcases key features of Veeva CDB, including the Study Dashboard, Dynamic Queries, and Automated Protocol Deviations. These tools enhance risk-based review and automate data workflows..., improving data quality and speed in clinical trials.
Show More..

Veeva Systems introduces the Veeva Clinical Operations Global Directory, part of its Clinical Operations Suite. This tool aims to replace Excel trackers and facilitate document reuse, enhancing trial... efficiency and accelerating study timelines.
Show More..

Veeva Systems is expanding its AI and Vault CRM capabilities, driving momentum in the life sciences sector. The company is enhancing its AI strategy through partnerships with BioMarin and Roche and a...cquiring Ostro, an AI engagement platform. Veeva's Vault CRM adoption is growing, with 140 customers live, including top pharmaceutical firms. However, AI monetization and CRM transition challenges persist.
Show More..

Veeva Systems introduces the Business Rules Engine in Veeva Vault CRM Events Management, enhancing compliance for pharma events. This tool automates processes like expense estimates and speaker rules..., reducing compliance risks. It offers configurable rule sets for attendee requirements and event materials, ensuring accurate event planning and execution.
Show More..

Veeva Systems has released the Veeva Vault Medical 24R1, featuring new connections, increased automation, and various enhancements for medical teams.

Veeva Systems introduces CRM innovations in the 21R3 release, enhancing productivity and engagement for commercial and medical teams.

Veeva Systems' Submissions Archive is a secure global repository for regulatory submissions, offering dynamic search, filtering, and navigation. It supports all electronic and paper formats, providin...g a comprehensive view of submissions and health authority interactions. The platform is trusted by over 400 biopharma companies for its efficiency in regulatory processes and global readiness.
Show More..

Veeva Systems has integrated Microsoft Teams and Outlook with its Veeva Vault CRM, enhancing meeting coordination and scheduling for biopharma teams. This integration allows users to synchronize cale...ndars, conduct video meetings, and manage schedules efficiently, leveraging Veeva's CRM capabilities alongside Microsoft's productivity tools.
Show More..

Veeva Systems introduces Veeva Commercial Insights, a tool designed to connect field insights with commercial decision-makers. This solution uses AI and human input to tag insights and identify comme...rcial themes, which are then shared with leaders via a web app. It aims to enhance decision-making and will be available to early adopters in 2026.
Show More..

Veeva Systems has introduced MyVeeva for Patients, a new application designed to facilitate patient-centric and paperless clinical trials. The application supports virtual visits, ePRO, eConsent, and... eSource capabilities, allowing for remote collaboration between patients, doctors, and clinical research coordinators. MyVeeva integrates with Veeva SiteVault and is set to be available in December 2020.
Show More..

Veeva Systems has launched Veeva Vault Payments, a new application for its Vault CTMS, to streamline payments to clinical research sites. This add-on automates payment tracking, providing sponsors an...d CROs with enhanced financial visibility and accuracy. Vault Payments integrates with existing workflows, enabling faster and more transparent payments, and is already being implemented by three early adopters.
Show More..

Veeva Systems launched Veeva Vault Site Connect, a new application that automates information sharing between sponsors and clinical research sites, enhancing collaboration and speeding up clinical tr...ials. This application integrates with Veeva's existing Vault Clinical applications and SiteVault, improving processes like feasibility studies, document exchange, and patient status updates, ultimately reducing administrative tasks and improving study quality.
Show More..

Veeva Systems has integrated WhatsApp Business into its Vault CRM Engage platform, enhancing omnichannel engagement for biopharma companies. This integration allows field teams to use WhatsApp for co...mpliant, personalized communication with healthcare professionals (HCPs), ensuring adherence to Meta's rules and offering flexibility in communication channels. The addition aims to balance convenience and compliance, addressing HCP preferences for efficient, tailored interactions.
Show More..

Veeva Systems introduces Veeva LIMS, a cloud-based application designed to modernize quality control for virtual biopharma companies. The solution integrates QC data management, enhances stability st...udy management, and supports GMP compliance. It aims to streamline processes, reduce errors, and improve inspection readiness, facilitating efficient product development and commercial launch.
Show More..

Lotus Clinical Research has expanded its partnership with Veeva Systems by broadening its use of the Veeva Vault Clinical Suite. This strategic move enhances Lotus' clinical trial operations, reducin...g startup times and improving coordination with sponsors and sites. Veeva's integrated clinical applications support Lotus' growth and diversification in clinical research.
Show More..

Veeva Systems has formed strategic partnerships with Smith+Nephew and Snowflake. Smith+Nephew will standardize its global quality management on Veeva Quality Cloud, while the Snowflake partnership wi...ll connect Veeva Vault Platform with Snowflake's AI Data Cloud. These collaborations deepen Veeva's role in life sciences workflows, enhancing its position as core infrastructure for quality and analytics.
Show More..

Veeva Systems has partnered with Snowflake to integrate the Snowflake AI Data Cloud with the Veeva Vault Platform. This collaboration enhances Veeva's data capabilities, allowing life sciences organi...zations to use Veeva data for analytics and AI without moving core regulated data. The partnership supports Veeva's strategy to improve data management and interoperability, reinforcing its position in the life sciences data market.
Show More..

Snowflake and Veeva Systems have partnered to integrate AI capabilities in the life sciences sector. This collaboration connects Snowflake's AI Data Cloud with Veeva Vault, enabling seamless data int...egration for enhanced analytics and AI applications. The partnership aims to improve clinical trials, regulatory compliance, and commercial operations by providing rapid, cross-functional insights and automating data pipelines for better compliance and operational efficiency.
Show More..

Veeva Systems and OpenEvidence have formed a long-term partnership to co-develop Open Vista, an AI platform designed to enhance clinical trial access and accelerate drug discovery. This collaboration... will leverage Veeva's life sciences data with OpenEvidence's AI technology to improve patient access and understanding of medical needs. The first products are expected in 2026.
Show More..

LEO Pharma expands its partnership with Veeva Systems by leveraging Veeva Link for Key People to enhance engagement with scientific experts in dermatology. This integration aims to improve LEO Pharma...'s medical and sales teams' interactions with the scientific community, supporting the development of new treatments and advancing patient care.
Show More..

Veeva Systems has partnered with RegASK to enhance its Regulatory Information Management (RIM) capabilities. This collaboration integrates RegASKs AI-driven regulatory intelligence with Veeva's compl...iance systems, enabling life sciences companies to access real-time regulatory insights. The partnership aims to improve decision-making, compliance outcomes, and product approvals, strengthening Veeva's position in the life sciences software market.
Show More..

Veeva Systems has partnered with RegASK to enhance its Regulatory Information Management (RIM) capabilities. This collaboration integrates RegASK's AI-driven regulatory intelligence with Veeva's comp...liance systems, providing life sciences companies with real-time regulatory insights. The partnership aims to improve decision-making, compliance outcomes, and product approvals, strengthening Veeva's position in the life sciences software market.
Show More..

Veeva Systems and UCB have partnered to enhance patient experiences in clinical trials through digital solutions. UCB will adopt Veeva's ePRO and eConsent applications to streamline patient-reported ...outcomes and consent processes. This collaboration aims to set a new standard for digital clinical trials, leveraging Veeva's technology to improve trial efficiency and accessibility.
Show More..

Veeva Systems has partnered with RegASK to integrate AI-driven regulatory intelligence into its Regulatory Information Management (RIM) platform. This collaboration aims to enhance compliance workflo...ws for life sciences companies by connecting real-time regulatory signals to Veevas RIM offering. The integration focuses on improving response times to regulatory changes, emphasizing Veeva's role in AI-driven compliance support.
Show More..

RegASK has joined the Veeva AI Partner Program to integrate its regulatory intelligence platform with Veeva's Regulatory Information Management (RIM) system. This partnership aims to enhance life sci...ences organizations' ability to align regulatory intelligence with compliance systems, enabling faster regulatory decisions. The collaboration reflects a strategic shift in the life sciences industry towards proactive regulatory management.
Show More..

Veeva Systems has acquired Copli, a leader in medical, legal, and regulatory solutions, and launched Veeva Falcon MLR. This new solution aims to streamline content review processes by automating up t...o 70% of manual MLR tasks, enhancing compliance checks, and allowing reviewers to focus on strategic tasks. Veeva Falcon MLR integrates with Veeva PromoMats to expedite the review cycle for life sciences marketing teams.
Show More..

Veeva Systems has acquired Copli to launch Veeva Falcon MLR, a solution promising up to 70% reduction in manual MLR labor within five years. Falcon MLR automates compliance checks, allowing life scie...nces teams to focus on strategic roles. The solution integrates with Veeva PromoMats and targets marketing and MLR groups in the life sciences sector.
Show More..

Veeva Systems has acquired Copli, a leader in agentic MLR solutions, and launched Veeva Falcon MLR. This new solution aims to significantly reduce manual work and accelerate content review cycles for... marketing and MLR teams. Veeva Falcon MLR integrates with Veeva PromoMats to ensure compliance with industry regulations.
Show More..

Veeva Systems has acquired Copli to enhance its MLR processes, integrating Copli's technology to improve efficiency in content review and reduce manual labor by over 70% within five years. This acqui...sition aims to address bottlenecks in delivering critical information in the life sciences sector.
Show More..

Veeva Systems has acquired Copli and launched Falcon MLR to enhance content review processes. This acquisition aims to accelerate and streamline content management for life sciences companies.

Veeva Systems Inc. acquired Copli on June 23, 2026, and launched Veeva Falcon MLR, leveraging Copli's technology for marketing compliance management. This acquisition enhances Veeva's cloud-based sol...utions for the life sciences industry.
Show More..

Veeva Systems has acquired Ostro, an AI-powered brand engagement platform for life sciences, which will operate independently while enhancing Veeva's digital engagement capabilities. This acquisition... aims to strengthen Veeva's offerings in patient and doctor communication within the life sciences sector.
Show More..

Veeva Systems acquired Ostro, an AI-powered brand engagement platform, for $100 million to enhance direct communication between patients and healthcare professionals (HCPs). This acquisition aligns w...ith Veeva's strategy to integrate AI into its Vault platform, aiming to improve patient and HCP engagement by providing accurate, approved medical information. The move differentiates Veeva from horizontal platforms like Salesforce by focusing on industry-specific solutions for life sciences.
Show More..

Veeva Systems has acquired Ostro, an AI chat tool developer, for $100 million. Ostro's platform provides pharma companies with compliant drug information and engagement analytics. Post-acquisition, O...stro will remain independent but will integrate with Veeva's cloud software to enhance patient and doctor interactions.
Show More..

Veeva Systems announced the acquisition of Ostro for approximately $100 million. Ostro, a brand engagement platform in life sciences, will operate independently under CEO Chase Feiger. The acquisitio...n aims to integrate Ostro with Veeva's Commercial Cloud applications to enhance customer-centric workflows.
Show More..

Veeva Systems has acquired Ostro for approximately $100 million. Ostro will operate as an independent unit under CEO Chase Feiger. The acquisition aims to integrate Ostro's brand engagement platform ...with Veeva's Commercial Cloud applications, enhancing workflows in life sciences. Ostro's AI-led chat experience provides compliant answers to patients and doctors, supporting faster access to accurate information.
Show More..

Veeva Systems has acquired Ostro, an AI-powered brand engagement platform for the life sciences industry, for approximately $100 million. This acquisition aims to enhance Veeva's Commercial Cloud by ...integrating Ostro's conversational AI capabilities, enabling pharmaceutical companies to provide real-time, compliant responses to healthcare professionals and patients. The move is expected to strengthen Veeva's position in AI-driven customer engagement and support long-term growth.
Show More..

Veeva Systems has acquired Ostro, a platform specializing in AI-driven, compliant communications for life sciences. This acquisition enhances Veeva's commercial offerings by integrating AI tools for ...personalized engagement with healthcare professionals and patients. The move aims to strengthen Veeva's position in the life sciences sector, focusing on compliant digital interactions.
Show More..

Veeva Systems has acquired Ostro, a brand engagement platform for life sciences, for $100 million. Ostro's AI-driven chat technology will integrate with Veeva Commercial Cloud, enhancing pharma brand... engagement. The acquisition, set to close in Q2 2026, will see Ostro operate independently under CEO Chase Feiger.
Show More..

Veeva Systems has acquired Ostro, a leading brand engagement platform for life sciences, for approximately $100 million. Ostro provides AI-driven, compliant chat experiences for patients and doctors,... enhancing brand engagement and insights. The acquisition aims to integrate Ostro with Veeva's Commercial Cloud applications, improving customer engagement workflows. Ostro will operate independently under CEO Chase Feiger.
Show More..

Veeva Systems has acquired Ostro, an AI-driven brand engagement platform for life sciences, for $100 million. This acquisition enhances Veeva's commercial software portfolio by adding a patient- and ...physician-facing engagement layer. Ostro's platform uses conversational AI to provide drug information, integrating with Veeva's CRM. The acquisition aims to create a unified commercial cloud, linking digital engagement with field activities.
Show More..

Veeva Systems has acquired Ostro, a brand engagement firm, for $100 million. Ostro's AI-powered tools, which aid pharma companies in engaging with doctors and patients, will integrate with Veeva's Co...mmercial Cloud. This acquisition enhances Veeva's offerings in the life sciences sector, following its recent purchase of Yonalink for clinical trial management.
Show More..

Veeva Systems has acquired Ostro, a company specializing in AI chat tools for the pharmaceutical industry, for $100 million. This acquisition aims to enhance Veeva's offerings in the life sciences se...ctor by integrating advanced AI capabilities.
Show More..

Veeva Systems has acquired Ostro, a leading brand engagement platform for life sciences, for approximately $100 million. Ostro, which uses AI to provide compliant and immediate responses to patients ...and physicians, will operate as an independent unit under CEO Chase Feiger. Veeva plans to integrate Ostro with its Commercial Cloud applications to enhance customer engagement.
Show More..

Veeva Systems has acquired Ostro, a leading AI-driven brand engagement platform for life sciences, for $100 million. Ostro enhances patient and doctor interactions with compliant, real-time responses.... It will operate independently, integrating with Veeva's Commercial Cloud to improve customer engagement. This acquisition aims to expand Veeva's AI capabilities in the life sciences sector.
Show More..

Veeva Systems has acquired Ostro, a leading AI-driven brand interaction platform for life sciences, for approximately $100 million. Ostro will operate independently, led by CEO Chase Feiger, and will... eventually integrate with Veeva's Commercial Cloud applications to enhance customer interactions. This acquisition aims to improve access to accurate information for patients and doctors, leveraging Ostro's compliance-focused AI technology.
Show More..

Veeva Systems has acquired Ostro, a leading AI-driven brand engagement platform for life sciences, for approximately $100 million. Ostro will operate independently, focusing on seamless integrations ...with Veeva's Commercial Cloud to enhance customer engagement. The acquisition aims to provide instant, compliant information access for patients and physicians, leveraging Ostro's conversational AI and semantic search capabilities.
Show More..

Veeva Systems is acquiring AI firm Ostro for $100 million to enhance its AI capabilities for healthcare providers. Ostro will operate independently, focusing on integrating AI-driven workflows that e...nable direct digital engagement between pharma brands and healthcare providers. This acquisition aims to scale regulated, AI-driven engagement in the life sciences sector.
Show More..

Veeva Systems acquires Ostro, a brand engagement platform, for $100 million, enhancing its capabilities in life sciences industry cloud solutions.

Veeva Systems has acquired Ostro, a brand engagement platform for life sciences, for $100 million. Ostro's AI-driven chat technology will enhance Veeva's offerings by providing compliant, real-time m...edical information on brand websites. Ostro will remain independent under CEO Chase Feiger, focusing on integrating with Veeva's Commercial Cloud applications.
Show More..

Veeva Systems has acquired Ostro, a leading brand engagement platform for life sciences, for approximately $100 million. Ostro will operate as an independent unit, led by CEO Chase Feiger, and will i...ntegrate with Veeva's Commercial Cloud applications to enhance customer engagement. Ostro's AI-driven platform provides compliant, real-time information to patients and doctors, improving brand reach and engagement.
Show More..

Veeva Systems has acquired AI chat platform Ostro for $100 million to enhance life sciences customer engagement. Ostro's technology provides real-time, compliant answers from medically reviewed mater...ials, improving patient and doctor interactions. The acquisition aligns with Veeva's vision to integrate AI into its Commercial Cloud applications, aiming for a unified, customer-centric model in the healthcare industry.
Show More..

Veeva Systems has acquired Ostro, a brand engagement platform for the life sciences industry, for $100 million. This acquisition aims to enhance Veeva's AI and automation capabilities within its clin...ical and commercial ecosystems. Ostro will operate independently, led by CEO Chase Feiger, and will continue to provide AI-driven, MLR-compliant responses to medical queries.
Show More..

Veeva Systems has acquired Ostro for $100 million to enhance its AI-driven customer engagement capabilities in the healthcare sector. Ostro, known for its AI-powered tools, will initially operate ind...ependently under CEO Chase Feiger before integrating with Veeva's Commercial Cloud applications. This acquisition aims to improve brand engagement and strengthen Veeva's position in the AI customer engagement market.
Show More..

Veeva Systems reported its Q1 2027 earnings, with earnings per share of $2.24, surpassing estimates by $0.07. The company also exceeded revenue expectations, reporting $882.95 million against an esti...mated $870.72 million.
Show More..

Veeva Systems corrected its financial outlook due to inaccuracies in prior reports. The company adjusted its revenue and earnings projections to provide a more accurate view of its anticipated financ...ial performance. Veeva is implementing stricter verification processes for future communications to prevent similar errors.
Show More..

Veeva Systems will announce its fiscal 2027 first quarter financial results on June 3, 2026. The company will host a conference call and webcast to discuss the results.

Veeva Systems achieved a significant milestone by surpassing $3 billion in revenue for fiscal year 2026, reaching $3.195 billion. The company recorded $836 million in the fourth quarter, driven by a ...16% increase in subscription revenue. Veeva's non-GAAP EPS was $2.06, exceeding expectations, with a 43.8% operating margin and $1.39 billion in operating cash flow.
Show More..

Veeva Systems will join the S&P 500 Index on May 7, 2026, replacing Coterra Energy. This inclusion is expected to boost Veeva's visibility and attract significant institutional investment, enhancing ...its role in the pharmaceutical and biotechnology sectors. The company recently reported strong financial results and announced a $2 billion share repurchase program.
Show More..

Veeva Systems will be added to the S&P 500 index, replacing Coterra Energy following its acquisition by Devon Energy. This inclusion signifies Veeva's growing influence and recognition in the market.

Veeva Systems will join the S&P 500 index on May 7, replacing Coterra Energy. This inclusion is expected to attract more fund managers to purchase Veeva's shares, potentially boosting its stock price.... Veeva reported a quarterly profit of $244 million on $836 million in revenue, reflecting a 16% year-over-year growth, driven by strong sales in its cloud software for the life sciences sector.
Show More..

Veeva Systems reported Q4 FY2026 revenue of $836 million, surpassing guidance and achieving a full-year revenue of $3.195 billion. The R&D Cloud was a key growth driver, with notable wins in the phar...maceutical sector. Veeva guided for 13% subscription revenue growth in FY2027, focusing on early-stage, high-growth products. The company continues to expand its Vault CRM platform among top pharmaceutical companies.
Show More..

Veeva Systems reported Q4 fiscal 2026 revenues of $836 million, surpassing estimates and reflecting a 16% year-over-year growth. Non-GAAP EPS was $2.06, exceeding expectations. The company projects F...Y2027 revenues of $3.585-$3.600 billion, driven by subscription services and AI initiatives. Veeva's robust performance underscores its competitive position in life sciences cloud solutions.
Show More..

Veeva Systems reiterated its confidence in achieving its 2030 financial targets despite competitive pressures in the CRM market, particularly from Salesforce. The company highlighted strong fiscal th...ird-quarter results and issued guidance above market expectations. However, concerns over lower-than-expected Vault CRM customer growth led to a 25% stock sell-off.
Show More..

Veeva Systems reported strong Q4 results for 2026, surpassing market expectations. Despite a cautious outlook, analysts maintain a positive sentiment, with over 70% holding a bullish view. The compan...y's integrated platform offers a competitive edge, and its guidance reflects customer planning cycles. Analysts have adjusted price targets, citing software multiple compressions, but continue to rate Veeva as a Buy.
Show More..

Veeva Systems reported strong Q4 financial results, surpassing market expectations with $836 million in revenue. The company's growth was driven by increased demand for system updates in safety and R...&D, and an expanded client base among major pharmaceutical firms. Adjusted earnings per share reached $2.06, and the operating margin improved from the previous year.
Show More..

Veeva Systems reported Q4 fiscal 2026 revenue of $836 million, surpassing expectations and highlighting strong market demand. The company achieved a total revenue of $3.195 billion for the fiscal yea...r, exceeding its $3 billion goal. Veeva's strategic partnerships and increased customer migration to its Vault CRM system contributed to this growth. The company plans to focus on AI integration for future product development.
Show More..

Veeva Systems reported strong Q4 fiscal 2026 results, with adjusted EPS of $2.06 and revenues of $836 million, both surpassing estimates. The company saw significant growth in its Subscription servic...es and Professional services segments. Veeva also provided optimistic guidance for fiscal 2027, expecting revenues between $3,585 million and $3,600 million and continued expansion of its AI capabilities and customer base.
Show More..

Veeva Systems reported strong Q4 fiscal 2026 results, with adjusted EPS of $2.06 and revenues of $836 million, both surpassing estimates. The company's subscription services and professional services... segments showed significant growth. Veeva also provided optimistic guidance for fiscal 2027, expecting revenues between $3.585 billion and $3.6 billion. The company continues to expand its AI capabilities and customer base in the life sciences sector.
Show More..

Veeva Systems anticipates an adjusted EPS of approximately $8.85 for fiscal 2027. The company also projects its fiscal 2027 revenue to range between $3.585 billion and $3.60 billion, aligning closely... with FactSet estimates of $3.56 billion. This guidance reflects Veeva's strategic positioning in the life sciences industry, leveraging its cloud solutions to drive growth.
Show More..

Veeva Systems reported a 16% increase in revenue for Q4 2026, totaling $835.95 million, surpassing analyst expectations. The EPS of $2.06 also exceeded estimates. Subscription services revenue rose b...y 16.3%, driven by Veeva R&D and Commercial Solutions. Despite strong financial performance, Veeva's stock has declined by 2.6% over the past month.
Show More..

Veeva Systems reported its fiscal year 2026 results, showing a 16% increase in total revenues to $3.195 billion. Subscription revenues rose by 17% to $2.684 billion. The company highlighted strong pe...rformance in its Commercial, Development, and Quality Clouds, with significant customer wins in biopharma. Veeva aims for a $6 billion revenue run rate by 2030, driven by its integrated AI solutions and expanding customer base.
Show More..

Veeva Systems reported an increase in its fiscal Q4 non-GAAP earnings and revenue, and provided an optimistic outlook for the upcoming fiscal year. The company anticipates fiscal 2027 adjusted EPS of... approximately $8.85 and a revenue range of $3.585 billion to $3.60 billion, surpassing FactSet estimates.
Show More..

Veeva Systems reported a 16% increase in FY26 revenue, reaching $3.2 billion, highlighting significant growth in its industry cloud solutions for life sciences.

Veeva Systems reported a significant increase in its Q4 earnings, with profits rising to $244.20 million, or $1.45 per share, compared to $195.62 million, or $1.18 per share, last year. Adjusted earn...ings were $346.12 million, or $2.06 per share. Revenue increased by 16% to $835.95 million. The company provided guidance for the next quarter, expecting EPS between $2.13 and $2.14 and revenue between $855 million and $858 million.
Show More..

Veeva Systems reported a Q4 non-GAAP EPS of $2.06, surpassing expectations by $0.12, and achieved a 16% year-over-year revenue increase to $835.95 million. The company projects Q1 FY2026 revenues bet...ween $855 million and $858 million, with updated FY2027 guidance forecasting revenues between $3.585 billion and $3.6 billion, reflecting strong demand for its subscription services.
Show More..

Veeva Systems has become the first publicly traded company to convert to a Public Benefit Corporation (PBC), following overwhelming shareholder approval. This transition aligns Veeva's legal charter ...with its mission to balance the interests of customers, employees, partners, and shareholders, supporting its commitment to stakeholder capitalism and long-term value creation.
Show More..

Veeva Systems will join the S&P 500 on May 7, replacing Coterra Energy. This inclusion reflects market confidence in Veeva's performance, as evidenced by a stock price increase on May 1. The company ...is also migrating customers to its Vault CRM system, aiming for completion by 2029, which is expected to enhance margins and technical control.
Show More..

Veeva Systems Inc. has been added to multiple S&P indices, including the S&P 500, S&P 500 Growth, and S&P 500 Health Care indices. This inclusion reflects Veeva's significant role in the health care ...and technology sectors.
Show More..